This work demonstrates a stable catalyst for olefin epoxidation, indicating advances in catalyst design and stability.
In this work, a highly stable heterogeneous catalyst with an adamantane topology was synthesized by loading a mixed-valence {V₁₆} cluster onto a metal-organic framework: H₃[Na(N₂C₆H₁₂)₂]₂[V₈IVV₈VO₃₈Cl]·3H₂O (NENU-MV-6). Nanoscale regulation of crystal morphology was achieved by modulating reaction solvents to influence nucleation and growth rates, yielding micronanocrystals (NENU-MV-6n) with a size distribution of around 500 nm. These crystals retain the tetrahedral morphology of NENU-MV-6 while exhibiting high thermal, acid-base, and solvent stability. Under oxygen-based oxidation conditions, NENU-MV-6n demonstrated excellent catalytic activity, selectivity, and universality toward olefin derivatives when used as a heterogeneous catalyst for olefin epoxidation. Furthermore, NENU-MV-6n exhibited outstanding cycling stability, showing no significant decline in catalytic activity after ten cycles. In summary, designing the structure and size of polyoxovanadate-based metal-organic frameworks (POV-MOFs) can effectively enhance catalyst stability and catalytic activity, providing new insights for the synthesis and nanoscale regulation of alkaline earth metal polyoxometalate hybrids.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: